These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4634660)

  • 21. [Efficacious treatment of a fatal blood disease: polycythemia vera].
    Sánchez Fayos J; Román Barbero A; Nevado Reviriego I
    Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264
    [No Abstract]   [Full Text] [Related]  

  • 22. Pipobroman (Vercyte) - a new antineoplastic drug.
    Med Lett Drugs Ther; 1967 Apr; 9(7):27. PubMed ID: 5298493
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of post-renal transplant erythrocytosis with enalapril.
    Rostaing L; Boisseau M; Durand D; Huyn A; Lloveras JJ; Suc JM
    Transplant Proc; 1993 Jun; 25(3):2325-6. PubMed ID: 8516915
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytogenetic response to pipobroman in Philadelphia-positive chronic myeloid leukemia with thrombocythemic onset.
    Orlandi E; Bernasconi P; Boni M; Calatroni S; Lazzarino M
    Ann Hematol; 2005 Feb; 84(2):127-8. PubMed ID: 15378276
    [No Abstract]   [Full Text] [Related]  

  • 25. [Efficacy of pipobroman in the treatment of essential thrombocythemia].
    Bauters F; Jouet JP; Simon M; Pollet JP; Fenaux P; Walter MP
    Presse Med; 1988 Jan; 17(2):81. PubMed ID: 2964031
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of the consensus conference on polycythemia vera. An opportunity to change or a sign of change?
    Pazart L; Carpentier F; Durocher A; Mougeot C; Najean Y; Godeau P
    Int J Technol Assess Health Care; 1999; 15(3):602-7. PubMed ID: 10874386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the therapeutic agents used in the management of polycythaemia vera.
    McMullin MF
    Hematol Oncol; 2007 Jun; 25(2):58-65. PubMed ID: 17352450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The mechanisms of the erythropoiesis inhibiting action of estrogen hormones].
    Peschle C; Tallarida G; Semprini A; Perroni L; Sasso GF; Condorelli M
    Boll Soc Ital Biol Sper; 1968 Mar; 44(5):344-8. PubMed ID: 5674604
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vaquez disease. Diagnosis, course, treatment].
    Bauters F
    Rev Prat; 1998 Sep; 48(13):1483-9. PubMed ID: 10050634
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of circulating total erythrocyte volume in polycythemia].
    Sasa S; Takaku S
    Naika; 1967 Aug; 20(2):330-3. PubMed ID: 5586783
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug.
    Passamonti F; Cazzola M
    Haematologica; 2004 Nov; 89(11):1284. PubMed ID: 15531447
    [No Abstract]   [Full Text] [Related]  

  • 32. More on polycythemia.
    Pinkie EA
    Adv Nurse Pract; 2002 May; 10(5):21. PubMed ID: 12420524
    [No Abstract]   [Full Text] [Related]  

  • 33. [Present treatment of the Vaquez's disease].
    Vallée G; Boivin P; Dormont J; Soulier JP
    Presse Med (1893); 1969 Mar; 77(14):517-9. PubMed ID: 5783371
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of long-term therapy of essential polycythemia using myleran. Definition of criteria for an adequate posology].
    Maurice PA; Alberto P
    Schweiz Med Wochenschr; 1967 Nov; 97(44):1477-8. PubMed ID: 5593694
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of the treatment of polycythemia vera with Vercyte].
    Polubiec A; Kolakowska-Polubiec K
    Wiad Lek; 1969 Dec; 22(23):2139-44. PubMed ID: 4904660
    [No Abstract]   [Full Text] [Related]  

  • 36. [Value of analyzing reticulocyte subpopulations in polycythemia].
    Ataulfo González F; Bermejo A; Sánchez J; Anguita E; Villegas A
    Sangre (Barc); 1997 Oct; 42(5):383-6. PubMed ID: 9424738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemotherapy against polycythemia due to a cyanotic congenital heart disease in adults. One case report].
    Boussaada R; Békir S; Ben Romdhane N; Mechmèche R
    Tunis Med; 2007 May; 85(5):437-40. PubMed ID: 17657936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. For excess red blood cells, DDx dictates the therapy.
    Zucker S; Distefano JF
    Geriatrics; 1981 Jan; 36(1):47-58. PubMed ID: 7450504
    [No Abstract]   [Full Text] [Related]  

  • 39. [Erythropoietin determination in hypernephroma with polycythemia].
    Pietschmann H; Vormittag W
    Wien Z Inn Med; 1970; 51(5):217-26. PubMed ID: 5523707
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of polycythemia vera with melphalan (Alkeran)].
    de Vries SI
    Ned Tijdschr Geneeskd; 1973 Mar; 117(9):337-43. PubMed ID: 4730686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.